tiprankstipranks
Trending News
More News >
Verona Pharma Plc (VRNA)
NASDAQ:VRNA
US Market

Verona Pharma (VRNA) Technical Analysis

Compare
830 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
6Neutral
1Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Verona Pharma Plc’s (VRNA) Moving Averages Convergence Divergence (MACD) indicator is 5.17, suggesting Verona Pharma Plc is a Buy.
Verona Pharma Plc’s (VRNA) 20-Day exponential moving average is 89.92, while Verona Pharma Plc’s (VRNA) share price is $94.58, making it a Buy.
Verona Pharma Plc’s (VRNA) 50-Day exponential moving average is 80.79, while Verona Pharma Plc’s (VRNA) share price is $94.58, making it a Buy.

Verona Pharma (VRNA) Pivot Points

Jul 02, 2025, 01:38 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
90.38
91.63
92.72
93.97
95.07
96.32
97.41
Fibonacci
91.63
92.53
93.08
93.97
94.87
95.42
96.32
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Verona Pharma (VRNA) Moving Averages

Jul 02, 2025, 01:38 AM
Period
Simple
Exponential
MA5
95.03Sell
94.52Buy
MA10
94.30Buy
93.53Buy
MA20
90.60Buy
89.92Buy
MA50
78.15Buy
80.79Buy
MA100
70.36Buy
71.26Buy
MA200
54.96Buy
56.40Buy
Verona Pharma Plc’s (VRNA) 10-Day exponential moving average is 93.53, while Verona Pharma Plc’s (VRNA) share price is $94.58, making it a Buy.
Verona Pharma Plc’s (VRNA) 100-Day exponential moving average is 71.26, while Verona Pharma Plc’s (VRNA) share price is $94.58, making it a Buy.
Verona Pharma Plc’s (VRNA) stock price is $94.58 and Verona Pharma Plc’s (VRNA) 50-day simple moving average is 78.15, creating a Buy signal.
Verona Pharma Plc’s (VRNA) stock price is $94.58 and Verona Pharma Plc’s (VRNA) 100-day simple moving average is 70.36, creating a Buy signal.
Verona Pharma Plc’s (VRNA) stock price is $94.58 and Verona Pharma Plc’s (VRNA) 200-day simple moving average is 54.96, creating a Buy signal.

Verona Pharma (VRNA) Technical Indicators

Jul 02, 2025, 01:38 AM
Name
Value
Implied Action
RSI (14)
68.57
Neutral
STOCH (9,6)
49.11
Neutral
STOCHRSI (14)
69.82
Neutral
MACD (12,26)
5.17
Buy
ADX (14)
36.77
Neutral
Williams %R
-30.96
Buy
CCI (14)
68.77
Neutral
ATR (14)
3.10
-
Ultimate Oscillator
54.19
Neutral
ROC
11.74
Buy
Verona Pharma Plc’s (VRNA) Relative Strength Index (RSI) is 68.57, creating a Neutral signal.
Verona Pharma Plc’s (VRNA) Trend Strength Indicator (ADX) is 36.77, creating a Neutral signal.
Verona Pharma Plc’s (VRNA) Commodity Channel Index (CCI) is 68.77, creating a Neutral signal.
Verona Pharma Plc’s (VRNA) Price Rate of Change (ROC) is 11.74, creating a Buy signal.

FAQ

Is VRNA a Buy, Hold, or Sell?
Based on VRNA’s technical indicators, VRNA is a Strong Buy.
    What is VRNA’s RSI (14)?
    VRNA’s RSI (14) is 68.57, which suggests VRNA is a Neutral.
      What is VRNA’s MACD?
      VRNA’s MACD is 5.17, which suggests VRNA is a Buy.
        What is VRNA’s 5-day moving average?
        VRNA’s 5-day moving average is 95.03, which suggests VRNA is a Sell.
          What is VRNA’s 20-day moving average?
          VRNA 20-day moving average is 90.60, which suggests VRNA is a Buy.
            What is VRNA’s 50-day moving average?
            VRNA’s 50-day moving average is 78.15, which suggests VRNA is a Buy.
              What is VRNA’s 200-day moving average?
              VRNA’s 200-day moving average is 54.96, which suggests VRNA is a Buy.
                What is VRNA’s Williams % R (14)?
                VRNA’s Williams % R (14) is -30.96, which suggests VRNA is a Buy.
                  What is VRNA’s CCI (14)?
                  VRNA’s CCI (14) is 68.77, which suggests VRNA is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis